DAU Arxiu Digital de la Universitat Ramon Llull
Publication
Artículo científico (JournalArticle)
Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator raseglurant. Violet light illumination of JF-NP-26 induces a photochemical reaction prompting the active-drug’s release, which effectively controls mGlu5 receptor activity both in ectopic expressing systems and in striatal primary neurons. Systemic administration in mice followed by local light-emitting diode (LED)-based illumination, either of the thalamus or the peripheral tissues, induced JF-NP-26-mediated light-dependent analgesia both in neuropathic and in acute/tonic inflammatory pain models. These data offer the first example of optical control of analgesia in vivo using a photocaged mGlu5 receptor negative allosteric modulator. This approach shows potential for precisely targeting, in time and space, endogenous receptors, which may allow a better management of difficult-to-treat disorders.
Project:
MINECO I ISCIII / PN I+D SAF2014-55700-P
,
MINECO I ISCIII / PN I+D PCIN-2013–019 C03-03
,
MINECO I ISCIII / PN I+D PIE14
,
SUR del DEC / SGR 2014-SGR-1054
,
ICREA / ICREA Academia-2010 PCIN-2013–018 C03-02
,
Fundació La Marató TV3 / 20152031 SAF2014-58396-R
,
IWT / SBO-140028 PCIN-2013–017 C03-01
,
MINECO / PN I+D CTQ2014-57020-R
,
MINECO / PN I+D CTQ2013-48767-C3-1-R
,
MINECO / PN I+D CTQ2015-71896-REDT
,
MINECO / PN I+D 2014-SGR-109
,
SUR del DEC / 2014CTP0002 2014-SGR-304
,
MINECO / PN I+D 2016 FI_B1 00021